TOI
Oncology Institute, Inc.
Next earnings Aug 11, 2026 · consensus $-0.07 EPS, $159M rev
Last earnings +7.1% on 2026-05-07
$5.25
▲ +4.37%$5.25▲ +120.59%
over 1Y
L $2.05EODHDH $5.31
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+4.4%
1W+0.0%
1M+14.4%
3M+68.3%
YTD+43.1%
1Y+120.6%
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 8 analysts
Buy
Revenue grew 27.8% YoY; but unprofitable (net margin -12.1%).
Oncology Institute, Inc. shows $503M in FY2025 revenue (+27.8% YoY), a -12.1% net margin.
Sources: SEC EDGAR (CIK 0001799191, latest 10-Q filed 2026-05-07) · EODHD · as of 6/25/2026, 5:40:19 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.